Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 9/2023

22.06.2023 | Original Paper

The relationship between mitral regurgitant severity, symptoms, and exercise capacity in primary degenerative mitral regurgitation

verfasst von: Seth Uretsky, Lillian Aldaia, Leo Marcoff, Konstatinos Koulogiannis, Jonathan Ignacio, Andrea Vegh, Sakul Sakul, Linda D Gillam

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Although it is assumed that more severe MR is associated with a greater burden of symptoms and lower exercise capacity, the relationship between symptoms, exercise capacity, and mitral regurgitant severity has not been well studied. We prospectively studied 67 (63 ± 11 years, 72% male) patients with at least mild degenerative MR and left ventricular ejection fraction ≥ 50% who underwent stress echocardiography, CMR, and evaluation with the Kansas City Cardiomyopathy questionnaire (KCCQ). Symptoms and exercise capacity were evaluated in the context of MR severity. Patients reporting dyspnea had lower KCCQ symptom scores (79 ± 23 vs. 96 ± 9, p = 0.01) and achieved lower percentage of age and gender predicted METs (114 ± 37 vs. 152 ± 43%, p < 0.001) compared to those without dyspnea. There was no significant difference in MR volume between those with vs. without dyspnea by CMR (43 ± 26 ml vs. 51 ± 28 ml, p = 0.3) or echocardiography (64 ± 28 vs. 73 ± 41ml, p = 0.4). Those with severe MR by CMR had similar KCCQ symptom scores (96 ± 10 vs. 89 ± 17, p = 0.04) and percentage of age and gender predicted METs (148 ± 42 vs. 133 ± 47%, p = 0.2) to those without severe MR. Those with severe MR by echocardiography had similar KCCQ symptom score (93 ± 15 vs. 89 ± 16, p = 0.3) and percentage of age and gender predicted METs (138 ± 43 vs. 153 ± 46%, p = 0.2) to those without severe MR. Patients with degenerative MR assessed by CMR and stress echocardiography, there was no relationship between MR severity and either symptoms or exercise capacity. These findings highlight the disconnect between symptoms and the severity of MR and challenge the assumption that correcting MR can be counted on to improve symptom status in patients with degenerative MR.
Literatur
1.
Zurück zum Zitat Writing Committee M, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M et al (2021) 2020 ACC/AHA Guideline for the management of patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77(4):e25–e197CrossRef Writing Committee M, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M et al (2021) 2020 ACC/AHA Guideline for the management of patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77(4):e25–e197CrossRef
2.
Zurück zum Zitat Gillam LD, Schwartz A (2010) Primum non nocere: the case for watchful waiting in asymptomatic “severe” degenerative mitral regurgitation. Circulation 121(6):813–821 discussion 821CrossRefPubMed Gillam LD, Schwartz A (2010) Primum non nocere: the case for watchful waiting in asymptomatic “severe” degenerative mitral regurgitation. Circulation 121(6):813–821 discussion 821CrossRefPubMed
3.
Zurück zum Zitat Enriquez-Sarano M, Sundt TM (2010) 3rd: early surgery is recommended for mitral regurgitation. Circulation 121(6):804–811 discussion 812CrossRefPubMed Enriquez-Sarano M, Sundt TM (2010) 3rd: early surgery is recommended for mitral regurgitation. Circulation 121(6):804–811 discussion 812CrossRefPubMed
4.
Zurück zum Zitat Dulgheru R, Marchetta S, Sugimoto T, Go YY, Girbea A, Oury C, Lancellotti P (2017) Exercise Testing in Mitral Regurgitation. Prog Cardiovasc Dis 60(3):342–350CrossRefPubMed Dulgheru R, Marchetta S, Sugimoto T, Go YY, Girbea A, Oury C, Lancellotti P (2017) Exercise Testing in Mitral Regurgitation. Prog Cardiovasc Dis 60(3):342–350CrossRefPubMed
5.
Zurück zum Zitat Uretsky S, Argulian E, Supariwala A, Marcoff L, Koulogiannis K, Aldaia L, Chaudhry FA, Wolff SD, Gillam LD (2018) A comparative Assessment of echocardiographic parameters for determining primary mitral regurgitation severity using magnetic resonance imaging as a reference Standard. J Am Soc Echocardiogr 31(9):992–999CrossRefPubMed Uretsky S, Argulian E, Supariwala A, Marcoff L, Koulogiannis K, Aldaia L, Chaudhry FA, Wolff SD, Gillam LD (2018) A comparative Assessment of echocardiographic parameters for determining primary mitral regurgitation severity using magnetic resonance imaging as a reference Standard. J Am Soc Echocardiogr 31(9):992–999CrossRefPubMed
6.
Zurück zum Zitat Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM et al (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular magnetic resonance. J Am Soc Echocardiogr 30(4):303–371CrossRefPubMed Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM et al (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular magnetic resonance. J Am Soc Echocardiogr 30(4):303–371CrossRefPubMed
7.
Zurück zum Zitat Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CN, Lauer MS, Marwick TH, Pandey DK, Wicklund RH, Thisted RA (2005) The prognostic value of a nomogram for exercise capacity in women. N Engl J Med 353(5):468–475CrossRefPubMed Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CN, Lauer MS, Marwick TH, Pandey DK, Wicklund RH, Thisted RA (2005) The prognostic value of a nomogram for exercise capacity in women. N Engl J Med 353(5):468–475CrossRefPubMed
8.
Zurück zum Zitat Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A (1993) Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am Coll Cardiol 22(1):175–182CrossRefPubMed Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A (1993) Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am Coll Cardiol 22(1):175–182CrossRefPubMed
9.
Zurück zum Zitat Uretsky S, Gillam L, Lang R, Chaudhry FA, Argulian E, Supariwala A, Gurram S, Jain K, Subero M, Jang JJ et al (2015) Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol 65(11):1078–1088CrossRefPubMed Uretsky S, Gillam L, Lang R, Chaudhry FA, Argulian E, Supariwala A, Gurram S, Jain K, Subero M, Jang JJ et al (2015) Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol 65(11):1078–1088CrossRefPubMed
10.
Zurück zum Zitat Kampaktsis PN, Albert BJ, Kim J, Xie LX, Brouwer LR, Tehrani NH, Villanueva M, Choi DY, Szulc M, Ratcliffe MB et al (2019) Impact of mitral regurgitation severity and cause on Effort Tolerance-Integrated stress myocardial perfusion imaging and echocardiographic Assessment of patients with known or suspected coronary artery Disease Undergoing Exercise Treadmill Testing. J Am Heart Assoc 8(5):e010974CrossRefPubMedPubMedCentral Kampaktsis PN, Albert BJ, Kim J, Xie LX, Brouwer LR, Tehrani NH, Villanueva M, Choi DY, Szulc M, Ratcliffe MB et al (2019) Impact of mitral regurgitation severity and cause on Effort Tolerance-Integrated stress myocardial perfusion imaging and echocardiographic Assessment of patients with known or suspected coronary artery Disease Undergoing Exercise Treadmill Testing. J Am Heart Assoc 8(5):e010974CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Messika-Zeitoun D, Johnson BD, Nkomo V, Avierinos JF, Allison TG, Scott C, Tajik AJ, Enriquez-Sarano M (2006) Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J Am Coll Cardiol 47(12):2521–2527CrossRefPubMed Messika-Zeitoun D, Johnson BD, Nkomo V, Avierinos JF, Allison TG, Scott C, Tajik AJ, Enriquez-Sarano M (2006) Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J Am Coll Cardiol 47(12):2521–2527CrossRefPubMed
12.
Zurück zum Zitat Naji P, Griffin BP, Barr T, Asfahan F, Gillinov AM, Grimm RA, Rodriguez LL, Mihaljevic T, Stewart WJ, Desai MY (2014) Importance of exercise capacity in predicting outcomes and determining optimal timing of surgery in significant primary mitral regurgitation. J Am Heart Assoc 3(5):e001010CrossRefPubMedPubMedCentral Naji P, Griffin BP, Barr T, Asfahan F, Gillinov AM, Grimm RA, Rodriguez LL, Mihaljevic T, Stewart WJ, Desai MY (2014) Importance of exercise capacity in predicting outcomes and determining optimal timing of surgery in significant primary mitral regurgitation. J Am Heart Assoc 3(5):e001010CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bakkestrom R, Banke A, Christensen NL, Pecini R, Irmukhamedov A, Andersen M, Borlaug BA, Moller JE (2018) Hemodynamic characteristics in significant symptomatic and asymptomatic primary mitral valve regurgitation at Rest and during Exercise. Circ Cardiovasc Imaging 11(2):e007171CrossRefPubMed Bakkestrom R, Banke A, Christensen NL, Pecini R, Irmukhamedov A, Andersen M, Borlaug BA, Moller JE (2018) Hemodynamic characteristics in significant symptomatic and asymptomatic primary mitral valve regurgitation at Rest and during Exercise. Circ Cardiovasc Imaging 11(2):e007171CrossRefPubMed
Metadaten
Titel
The relationship between mitral regurgitant severity, symptoms, and exercise capacity in primary degenerative mitral regurgitation
verfasst von
Seth Uretsky
Lillian Aldaia
Leo Marcoff
Konstatinos Koulogiannis
Jonathan Ignacio
Andrea Vegh
Sakul Sakul
Linda D Gillam
Publikationsdatum
22.06.2023
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 9/2023
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-023-02881-3

Weitere Artikel der Ausgabe 9/2023

The International Journal of Cardiovascular Imaging 9/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.